Postherpetic Neuralgia

• FDA approval · 2006-09-13
  FDA Approved: GABAPENTIN — Original Application (Advagen Pharma Ltd)

  The FDA approved Advagen Pharma Ltd's Original Application for gabapentin, enabling a generic version of the anticonvulsant. The approval su…

• FDA approval · 2006-08-24
  FDA Approved: GABAPENTIN — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approves Sun Pharmaceutical's gabapentin as an original generic application, allowing market authorization for a gabapentin product.

• FDA approval · 2006-08-24
  FDA Approved: GABAPENTIN — Original Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a generic gabapentin product from Sun Pharmaceutical Industries as an Original Application (ANDA). The approval makes a generic…

• FDA approval · 2006-08-18
  FDA Approved: GABAPENTIN — Original Application (BluePoint Laboratories)

  The FDA approved BluePoint Laboratories' original application for gabapentin (generic). The approval covers its use as a generic option for …

• CLINICAL_TRIALS trial_result · 2006-08-08
  Clinical Trial Update: Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures [Phase 2]

  A Phase 2 trial evaluating S,S-Reboxetine for postherpetic neuralgia in gabapentin-treatment failures has been completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2006-05-03
  FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)

  FDA approved a supplemental application for Neurontin (gabapentin) submitted by Parke-Davis Div of Pfizer Inc.

• FDA approval · 2006-05-03
  FDA Approved: NEURONTIN — Supplemental Application (Parke-Davis Div of Pfizer Inc)

  The FDA approved a supplemental application for Neurontin (gabapentin) from Parke-Davis Div of Pfizer Inc, resulting in updated labeling.